Össur hf. provided earnings guidance for the year 2024. The company's organic sales growth guidance is 5%-8%, expected to be driven by continued strong volume growth and moderate price increases.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.7 DKK | +0.68% | 0.00% | +8.20% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.20% | 1.82B | |
-13.86% | 20.6B | |
-4.23% | 17.33B | |
+8.77% | 13.89B | |
-11.07% | 2.16B | |
+36.78% | 1.68B | |
+23.26% | 617M | |
0.00% | 434M | |
+38.70% | 154M | |
+14.35% | 94.55M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur hf. Provides Earnings Guidance for the Year 2024